Related Experiment Video
Updated: Jan 19, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
G-tract RNA removes Polycomb repressive complex 2 from genes
Manuel Beltran1, Manuel Tavares1, Neil Justin2
1UCL Cancer Institute and Cancer Research UK UCL Centre, University College London (UCL), London, UK.
Abstract:
Polycomb repressive complex 2 (PRC2) maintains repression of cell-type-specific genes but also associates with genes ectopically in cancer. While it is currently unknown how PRC2 is removed from genes, such knowledge would be useful for the targeted reversal of deleterious PRC2 recruitment events. Here, we show that G-tract RNA specifically removes PRC2 from genes in human and mouse cells. PRC2 preferentially binds G tracts within nascent precursor mRNA (pre-mRNA), especially within predicted G-quadruplex structures. G-quadruplex RNA evicts the PRC2 catalytic core from the substrate nucleosome. In cells, PRC2 transfers from chromatin to pre-mRNA upon gene activation, and chromatin-associated G-tract RNA removes PRC2, leading to H3K27me3 depletion from genes. Targeting G-tract RNA to the tumor suppressor gene CDKN2A in malignant rhabdoid tumor cells reactivates the gene and induces senescence. These data support a model in which pre-mRNA evicts PRC2 during gene activation and provides the means to selectively remove PRC2 from specific genes.
Insights
G-tract RNA, particularly G-quadruplex structures in precursor mRNA, removes Polycomb repressive complex 2 (PRC2) from genes. This mechanism reactivates tumor suppressor genes and offers a way to reverse aberrant PRC2 activity.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Biology
Background:
- Polycomb repressive complex 2 (PRC2) is crucial for gene repression but can be aberrantly recruited in cancer.
- Understanding PRC2 removal mechanisms is key for reversing detrimental gene silencing.
Purpose of the Study:
- To investigate how PRC2 is removed from genes.
- To identify mechanisms for targeted reversal of aberrant PRC2 recruitment.
Main Methods:
- Studied PRC2 binding to G-tract RNA and G-quadruplex structures in nascent pre-mRNA.
- Observed PRC2 transfer from chromatin to pre-mRNA during gene activation in human and mouse cells.
- Targeted G-tract RNA to the CDKN2A gene in malignant rhabdoid tumor cells.
Main Results:
- PRC2 preferentially binds G tracts in pre-mRNA, especially G-quadruplex structures.
- G-quadruplex RNA can evict the PRC2 catalytic core from nucleosomes.
- Chromatin-associated G-tract RNA mediates PRC2 removal upon gene activation, leading to H3K27me3 depletion.
- Targeting G-tract RNA to CDKN2A reactivated the gene and induced senescence in cancer cells.
Conclusions:
- Pre-mRNA, via G-tract RNA, plays a role in evicting PRC2 during gene activation.
- This mechanism provides a means for selective PRC2 removal from specific genes.
- G-tract RNA represents a potential therapeutic target for reactivating silenced tumor suppressor genes.
More Related Videos
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Related Concept Videos
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Inheritance of Chromatin Structures
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...
Heterochromatin
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...